You are here

Stuart Farrow

Director of Biology

Before joining CRUK-TDL (then CRT-DL) in April 2015, Stuart spent more than 20 years in drug discovery and leadership roles in the pharmaceutical industry. Most recently he was based at the University of Manchester, where he directed the establishment of the Manchester Centre for Collaborative Research in Inflammation (MCCIR), a £15M initiative funded by GlaxoSmithKline, AstraZeneca and the University of Manchester. He is currently a member of the MRC Infection and Immunity Board. Stuart has worked in several therapeutic areas, including autoimmune, inflammation and respiratory and has directed major translational research initiatives in apoptosis, immunology and circadian biology. He has led discovery teams that have generated several clinical candidate molecules and has overseen biology programmes for drugs that have achieved regulatory approval and launch. Stuart obtained his undergraduate degree in Chemistry and a postgraduate degree in biological chemistry from the University of Birmingham. He completed his postdoctoral training at the National Cancer Research Institute in Tokyo.